Computing Resources: Difference between revisions
Jump to navigation
Jump to search
(more right align) |
(total) |
||
| Line 21: | Line 21: | ||
|- | |- | ||
| RNASeq || Drug Screening || Leukemia Biology || || || || style="text-align:right;" |0.4 || | | RNASeq || Drug Screening || Leukemia Biology || || || || style="text-align:right;" |0.4 || | ||
|- | |||
| Total || style="text-align:right;" |4 || style="text-align:right;" |- || style="text-align:right;" |15 || style="text-align:right;" |26 || | |||
|- | |- | ||
|} | |} | ||
Revision as of 17:28, 15 April 2024
| Type of Data | Project | Lab | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| MRD | Routine | Molecular Biology | |||||
| Exome | Precision Medicine | Epigenomics | |||||
| ctDNA | Circular Tumoral DNA | Molecular Biology | |||||
| Methylome | Precision Medicine | Epigenomics | |||||
| Mass spectra | DESI | Leukemia Biology / Pathology | 4 | - | - | - | - |
| Imaging | Drug Screening | Leukemia Biology | 15 | 25 | |||
| Panel | Drug Screening | Leukemia Biology | 0.4 | ||||
| Methylome | Drug Screening | Leukemia Biology | 0.03 | ||||
| RNASeq | Drug Screening | Leukemia Biology | 0.4 | ||||
| Total | 4 | - | 15 | 26 |